SURPASS and the Case for Simulation-Based Trials

PharmTech explores the potential of simulation-based clinical trials in pharmaceutical development.

The pharmaceutical industry is increasingly turning to simulation-based clinical trials to improve efficiency and reduce costs. SURPASS, a digital twin of a clinical trial, has been used to model the effects of different treatment regimens on patient outcomes. This approach has the potential to reduce the number of patients required for clinical trials and speed up the development process.